[{"NetIncomeLoss_2_Q2_USD":-181000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-696000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":6089000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":12056000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":3075000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":6000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":4000.0,"AssetsCurrent_0_Q2_USD":115763000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q2_shares":3525000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":30870000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":14448000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":27524000.0,"InterestPaidNet_2_Q2_USD":1810000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":12477000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":118000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_2_Q2_USD":389000.0,"InventoryValuationReserves_0_Q2_USD":499000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_2_Q2_USD":-1350000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":-753000.0,"CommonStockSharesIssued_0_Q2_shares":166085000.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":11350000.0,"Assets_0_Q2_USD":143124000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":4000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":6000.0,"ShareBasedCompensation_2_Q2_USD":3965000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":19900000.0,"PreferredStockValueOutstanding_0_Q2_USD":null,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":7930000.0,"ContractWithCustomerAssetNetCurrent_0_Q2_USD":7013000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":5398000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":2417000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":2.47,"ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments_2_Q2_USD":14500000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":165566000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":169228000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":176000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":100000.0,"AccountsReceivableNetCurrent_0_Q2_USD":34293000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":1132000.0,"RevenueRemainingPerformanceObligation_0_Q2_USD":24400000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":-961000.0,"IncreaseDecreaseInInventories_2_Q2_USD":3605000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-175000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":2179000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":3680000.0,"OtherAssetsNoncurrent_0_Q2_USD":3049000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":43558000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":4980000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":335372000.0,"Liabilities_0_Q2_USD":85795000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"SharesPaidForTaxWithholdingForShareBasedCompensation_2_Q2_shares":419000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":2.31,"AccruedLiabilitiesCurrent_0_Q2_USD":18332000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":4860000.0,"ShortTermInvestments_0_Q2_USD":7992000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":2.89,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.01,"OtherOperatingActivitiesCashFlowStatement_2_Q2_USD":519000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":1350000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":3965000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":1987000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":9261000.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":325000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":165566000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":165703000.0,"LiabilitiesCurrent_0_Q2_USD":39974000.0,"AccountsPayableCurrent_0_Q2_USD":18071000.0,"InterestExpense_2_Q2_USD":2028000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":10379000.0,"InterestExpense_1_Q2_USD":967000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":3302000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_Q2_USD":1000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":389000.0,"LongTermDebtNoncurrent_0_Q2_USD":40647000.0,"GrossProfit_2_Q2_USD":37939000.0,"GrossProfit_1_Q2_USD":19907000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":43558000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":3334000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q2_USD":5997000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":19452000.0,"NetIncomeLoss_1_Q2_USD":2175000.0,"IncreaseDecreaseInContractWithCustomerAsset_2_Q2_USD":-1222000.0,"CommonStockSharesOutstanding_0_Q2_shares":166085000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-785000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":20357000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":106000.0,"CommonStockSharesAuthorized_0_Q2_shares":300000000.0,"CommonStockValueOutstanding_0_Q2_USD":1661000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":32384000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":65463000.0,"OperatingIncomeLoss_2_Q2_USD":1671000.0,"OperatingIncomeLoss_1_Q2_USD":3042000.0,"InventoryNet_0_Q2_USD":19605000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":2341000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":2.73,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":1.99,"LiabilitiesAndStockholdersEquity_0_Q2_USD":143124000.0,"PreferredStockSharesAuthorized_0_Q2_shares":3000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":243000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":1230000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":1247000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":0.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":0.01,"ProfitLoss_2_Q2_USD":-181000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":194000.0,"StockholdersEquity_0_Q2_USD":57329000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":2444000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":16498000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":11462000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-279008000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.01,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":603000.0,"Ticker":"ATRS","CIK":"1016169","name":"ANTARES PHARMA, INC.","OfficialName":"Antares Pharma Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"948492298.0","Country":"United States","Sector":"Health Care","Industry":"Medical\/Dental Instruments","Market":"NASDAQ","SP500":"nan","filed":"20200806"}]